Parkinson's disease anxiety
Conditions
Interventions
Experimental group:On the basis of maintaining the patient’s original dose of anti-parkinson's drugs, acupuncture method was given
Sponsors
The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
35 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.Diagnosis of idiopathic Parkinsons disease; 2.Hoehn and Yahr staging scale stage 1 to 4; 3.HAMA scale score ranged from 14 to 29; 4.Able to provide written informed consent; 5.Men or women aged 35 to 80 years.
Exclusion criteria
Exclusion criteria: 1.Significant neurologic, renal, cardiovascular or hepatic impairment; 2.Any disease can lead to Parkinsons syndrome or other conditions that are suspected to be related to the patients symptoms; 3.Significant cognitive impairment defined by MOCA < 23; 4.No significant response to high dose levodopa therapy; 5.Medical or psychiatric comorbidity that could compromise study participation; 6.Drug or alcohol use or dependence that could compromise study participation; 7.Exposure to study drug or acupuncture before 30 days of study entry; 8.Allergy or intolerance to acupuncture; 9.Subjects, who by investigators determination, will not be able to adhere to study protocol.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hamilton Anxiety Scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| The new version of the Parkinson's Disease Comprehensive Assessment Scale of the World Society for Movement Disorders;adrenocorticotropic hormone;Hydrocortisone;The Parkinson's Disease Questionnaire (PDQ-39):; | — |
Countries
China
Contacts
Public ContactFan Jingqi
The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Outcome results
None listed